MDGL
#806
Madrigal Pharmaceuticals, Inc. - Common Stock
543.6 9 USD
+0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.89%
Monthly Change
+0.39%
6 month change
+26.37%
Year Change
+28.35%
Previous Close
538.8 8
Open
543.6 9
Low
543.6 9
High
543.6 9
Volume
65
Financials
- Market Capitalization 12.56 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-45.32
Price to sales ratio
13.63
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 802 |  BMRN BioMarin Pharmaceutical Inc. - Common Stock | 65.29 USD | -0.49% | -3.35% | +5.19% | +13.47% | 12.64 B USD | ||
| 803 |  CORT Corcept Therapeutics Incorporated - Common Stock | 116.93 USD | -2.40% | -3.75% | +23.08% | +59.37% | 12.64 B USD | ||
| 809 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 88.59 USD | -0.59% | +0.50% | +3.54% | +126.57% | 12.51 B USD | ||
| 824 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 106.92 USD | -0.13% | +0.68% | +28.70% | +60.06% | 12.14 B USD |
Frequently asked questions about Madrigal Pharmaceuticals, Inc. Common Stock
What is the Madrigal Pharmaceuticals, Inc. Common Stock stock price today?
The current price of Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is 543.69. Over the past 24 hours, the stock has changed by +0.89%. Follow the MDGL chart for real-time price dynamics.
What is the stock ticker of Madrigal Pharmaceuticals, Inc. Common Stock?
Madrigal Pharmaceuticals, Inc. Common Stock trades under the ticker MDGL. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Madrigal Pharmaceuticals, Inc. Common Stock stock going up?
MDGL has changed by +3.94% over the last week, +0.39% over the last month, and +28.35% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Madrigal Pharmaceuticals, Inc. Common Stock?
Madrigal Pharmaceuticals, Inc. Common Stock currently has a market capitalization of 12.56 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Madrigal Pharmaceuticals, Inc. Common Stock earnings last quarter?
Last quarter, Madrigal Pharmaceuticals, Inc. Common Stock reported earnings of -1.99 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Madrigal Pharmaceuticals, Inc. Common Stock revenue for the last quarter?
Madrigal Pharmaceuticals, Inc. Common Stock reported quarterly revenue of 364.25 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Madrigal Pharmaceuticals, Inc. Common Stock net income for the last quarter?
Madrigal Pharmaceuticals, Inc. Common Stock reported net income of -57.94 M for the last quarter. The previous quarter showed -94.39 M, which means net income changed by +38.62%.
How many employees does Madrigal Pharmaceuticals, Inc. Common Stock have?
As of the latest available data, Madrigal Pharmaceuticals, Inc. Common Stock has 915 employees. Workforce size can provide additional context about the company's scale and operations.
What is Madrigal Pharmaceuticals, Inc. Common Stock EBITDA?
Madrigal Pharmaceuticals, Inc. Common Stock EBITDA is -66.33 M, and its EBITDA margin is -18.21%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Madrigal Pharmaceuticals, Inc. Common Stock stock?
You can buy Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Madrigal Pharmaceuticals, Inc. Common Stock stock?
Investing in Madrigal Pharmaceuticals, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MDGL chart and related analysis on metatrader.com as part of your research.